Carlisle (CSL) grants VP Gaskill restricted shares and stock options

Rhea-AI Filing Summary

Carlisle Companies executive Christopher Burke Gaskill received new equity awards. On January 28, 2026, he was granted 865 shares of common stock as restricted shares from the issuer in his role as an executive officer.

On the same date, he also received an employee stock option for 3,025 shares of Carlisle common stock at an exercise price of $341.01 per share, expiring on January 27, 2036. This option vests in three equal annual installments beginning on January 28, 2027, and all reported holdings are listed as directly owned.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Gaskill Christopher Burke

Role VP & General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	3,025	$0.00	--
Grant/Award	Common Stock	865	$0.00	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 3,025 shares (Direct); Common Stock — 865 shares (Direct)

Footnotes (1)

1. Represents a grant of 865 restricted shares from the issuer as an executive officer of the issuer. The option vests in three equal annual installments beginning on January 28, 2027.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gaskill Christopher Burke

(Last) (First) (Middle)

16430 N SCOTTSDALE RD

STE 400

(Street)

SCOTTSDALE AZ 85254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARLISLE COMPANIES INC [ CSL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		A		865(1)	A	$0	865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$341.01	01/28/2026		A		3,025		(2)	01/27/2036	Common Stock	3,025	$0	3,025	D

Explanation of Responses:

1. Represents a grant of 865 restricted shares from the issuer as an executive officer of the issuer.

2. The option vests in three equal annual installments beginning on January 28, 2027.

Remarks:

	/s/ Christopher B. Gaskill by Ronald P. Fuss, attorney-in-fact	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Carlisle (CSL) grant to Christopher Burke Gaskill?

Carlisle granted Christopher Burke Gaskill 865 restricted common shares and an option for 3,025 common shares at a $341.01 exercise price. These awards represent part of his executive compensation as VP & General Counsel and are directly owned.

When were Christopher Burke Gaskill’s new Carlisle (CSL) awards granted?

Both the restricted shares and stock options were granted on January 28, 2026. The Form 4 lists this as the transaction date for the 865 restricted shares and the 3,025-share employee stock option grant to the Carlisle executive.

How do Christopher Burke Gaskill’s new Carlisle stock options vest?

The 3,025-share option vests in three equal annual installments starting January 28, 2027. Each year, one-third of the option becomes exercisable, providing Gaskill with a long-term incentive that links his compensation to Carlisle’s future share performance.

What is the exercise price and expiration date of Gaskill’s Carlisle options?

The employee stock option has a $341.01 per share exercise price and expires on January 27, 2036. This long-dated option gives Gaskill the right to buy Carlisle common stock at that price if the vesting conditions are met.

How many Carlisle (CSL) shares does Gaskill own after these grants?

After the reported transactions, Gaskill beneficially owns 865 shares of Carlisle common stock directly, all from the restricted share grant. He also directly holds an option covering 3,025 shares of Carlisle common stock, subject to its vesting schedule and terms.

What is Christopher Burke Gaskill’s role at Carlisle (CSL)?

Christopher Burke Gaskill is listed as an officer of Carlisle with the title VP & General Counsel. The Form 4 shows these equity awards—865 restricted shares and 3,025 stock options—as compensation connected to his executive responsibilities at the company.